FDA Panel Casts SSRIs During Pregnancy as Risky-Many Experts Disagree

Lauren Schneider

doi:10.1001/jama.2025.14105

FDA Panel Casts SSRIs During Pregnancy as Risky-Many Experts Disagree

JAMA. 2025 Sep 16;334(11):937-939. doi: 10.1001/jama.2025.14105.

Author

Lauren Schneider¹

Affiliation

¹ New York University Arthur L. Carter Journalism Institute Science, Health & Environmental Reporting Program Intern, New York.

PMID: 40815508
DOI: 10.1001/jama.2025.14105

No abstract available

Plain language summary

This Medical News article discusses claims about antidepressant treatment during pregnancy presented at a recent panel organized by the US Food and Drug Administration.